Atossa Therapeutics, Inc.
ATOS
$1.88
$0.116.22%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 31.72M | 41.30M | 51.85M | 57.86M | 65.12M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | 3.01M | 3.08M | 3.14M | 3.48M | 2.08M |
| Prepaid Expenses | 722.00K | 585.00K | 239.00K | 509.00K | 886.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.22M | 653.00K | 451.00K | 676.00K | 663.00K |
| Total Current Assets | 36.67M | 45.62M | 55.68M | 62.52M | 68.74M |
|
|
|||||
| Total Current Assets | 36.67M | 45.62M | 55.68M | 62.52M | 68.74M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.28M | 1.99M | 2.33M | 2.00M | 2.00M |
| Total Assets | 37.94M | 47.61M | 58.01M | 64.52M | 70.75M |
|
|
|||||
| Total Accounts Payable | 2.57M | 4.29M | 3.54M | 2.01M | 1.17M |
| Total Accrued Expenses | 3.75M | 2.87M | 3.11M | 3.25M | 2.73M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 1.14M | 1.10M | 1.58M | 1.56M | 1.53M |
| Total Other Current Liabilities | 1.14M | 1.10M | 1.58M | 1.56M | 1.53M |
| Total Current Liabilities | 7.46M | 8.26M | 8.23M | 6.82M | 5.43M |
|
|
|||||
| Total Current Liabilities | 7.46M | 8.26M | 8.23M | 6.82M | 5.43M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 7.46M | 8.26M | 8.23M | 6.82M | 5.43M |
|
|
|||||
| Common Stock & APIC | 288.11M | 287.39M | 286.89M | 286.10M | 285.31M |
| Retained Earnings | -256.15M | -246.56M | -235.63M | -226.93M | -218.51M |
| Treasury Stock & Other | -1.48M | -1.48M | -1.48M | -1.48M | -1.48M |
| Total Common Equity | 30.49M | 39.35M | 49.79M | 57.70M | 65.32M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 30.49M | 39.35M | 49.79M | 57.70M | 65.32M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 30.49M | 39.35M | 49.79M | 57.70M | 65.32M |
|
|
|||||